Cancer BiologybioRxiv
14K Prolactin Derived 14-Mer Antiangiogenic Peptide Targets Bradykinin-/Nitric Oxide-cGMP-Dependent Angiogenesis
J. Lee, P. Kumar, S. Natarajan…·S. Chatterjee
This study identifies a novel 14-mer antiangiogenic peptide derived from prolactin that inhibits bradykinin- and eNOS-dependent angiogenesis, showing synergistic effects with Avastin in a colon cancer model.
DOI 10.1002/2211-5463.13895